Results 91 to 100 of about 26,095 (135)

Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis. [PDF]

Ren Fail
Wu X, Meng J, Yang Y, Sheng D, Liu X, Zhou Y.   +5 more
europepmc   +1 more source

Enhancing immune response in advanced HCC with PVTT: rivaroxaban as a core adjuvant in combined therapy. [PDF]

J Immunother Cancer
Yan Y, Zou D, Li Y, Ma H, Chen H.
europepmc   +1 more source

The application of low-dose rivaroxaban in elderly patients with atrial fibrillation. [PDF]

Front Pharmacol
Wang Z, Dai X, Huang Z, Hu J, Qu J, Wang P, Chen Q, Wang X.   +7 more
europepmc   +1 more source

Emergency reversal of Rivaroxaban with Andexanet alfa in a child with hemorrhagic brain metastasis from Wilms tumor. [PDF]

Childs Nerv Syst
Rafaelian A, Won SY, Mueller L, Armbrust M, Weber KJ, Haas A, Reuter DA, Freiman TM, Gessler F, Spang C, Meyer-Bahlburg A, Hingst P, Classen CF, Dubinski D, Cardesa-Salzmann TM.   +14 more
europepmc   +1 more source

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in real-world patients with pulmonary embolism in China. [PDF]

Res Pract Thromb Haemost
Ren J, Li Y, Zheng X, Wu Z, Shi J, Han X.   +5 more
europepmc   +1 more source

Oral Anticoagulants and Risk of Bleeding and Death in Cancer-Associated Venous Thromboembolism. [PDF]

JACC Adv
Lutsey PL, Walker RF, Adrianzen-Herrera D, Wang W, Giorgio K, Cogan J, Norby FL, Zakai NA.   +7 more
europepmc   +1 more source

Residue‑resolved dynamically averaged interaction analysis of direct factor Xa inhibitors by MD‑FMO combination calculations. [PDF]

J Comput Aided Mol Des
Yoshine R, Hirano Y, Doi H, Kitahara S, Akisawa K, Okuwaki K, Yamamoto E, Yasuoka K, Mochizuki Y.   +8 more
europepmc   +1 more source

Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial. [PDF]

Lupus Sci Med
Zhang Z, Li F, Li Y, Xie Z, Du J, Mao N, Li S, Liu Y, Ge Y, Wang J, Tang Q, Kang J, Peng X, Cheng W, Li Y, Xu P, Xiao Y, Tu T, Xie X, Liu Q.   +19 more
europepmc   +1 more source

Real-world use of rivaroxaban for primary thromboprophylaxis and cardiac thrombosis treatment in congenital and acquired heart disease: a prospective cohort study. [PDF]

Sci Rep
Derridj N, Malekzadeh-Milani S, Lasne D, Da Costa S, Khraiche D, Ndjoli H, Bonnet D, Bajolle F.   +7 more
europepmc   +1 more source

Pharmacovigilance study of spinal epidural hematoma reports associated with direct oral anticoagulants and warfarin. [PDF]

Acta Neurochir (Wien)
Porwal M, Stegamat N, Reddy V, Jaffee S, Kramer D, Cunningham C, Yu A.   +6 more
europepmc   +1 more source